DLDamien Logeart

Damien Logeart

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Damien Logeart has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • 0437: Impact of RV involvement on LV remodeling after acute MI

    by Teodor Vasile, Raphael Dautry, Mathilde Baudet, Damien Logeart, Helene Vernhet Kovacsik, Philippe Soyer, Jean-Jacques Mercadier, Marc Sirol

  • INDEX OF MICROCIRCULATORY RESISTANCE AS AN EARLY PREDICTIVE FACTOR OF LV REMODELING AFTER REPERFUSED MYOCARDIAL INFARCTION

    by Marc Sirol, Arthur Cescau, Georogios Sideris, Damien Logeart, Jean-Guillaume Dillinger, Jean-Jacques Mercadier, Patrick Henry

  • Transient worsening of renal function during hospitalization for acute heart failure alters outcome

    by Damien Logeart, Jean-Yves Tabet, Luc Hittinger, Gabriel Thabut, Patrick Jourdain, Patrick Maison, Jean-Michel Tartiere, Alain Cohen Solal


  • Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism

    by Damien Logeart, Lucien Lecuyer, Gabriel Thabut, Jean-Yves Tabet, Jean-Michel Tartière, Christophe Chavelas, François Bonnin, Jean-Louis Stievenart, Alain Cohen Solal

    Objective To evaluate the usefulness of B-type natriuretic peptide and troponin I measurements in predicting right ventricular dysfunction (RVD) in non-massive pulmonary embolism. Design Prospective observational study. Setting University-affiliated emergency unit, cardiology and pneumology departments. Patients Sixty-seven patients admitted because of acute pulmonary embolism, without shock on admission, completed the study. Interventions Blood samples and echocardiography were obtained on admission for subsequent and independent assessment of B-type natriuretic peptide (BNP) and troponin I levels as well as RVD. Measurements and results Echocardiographic RVD was diagnosed in 36 patients and was severe in 13 on admission. BNP and troponin I levels were higher in patients with RVD than in those with no RVD [62 (27–105) vs. 431 (289–556) pg/ml for BNP, p < 0.001; 0.01 (0–0.09) vs. 0.16 (0.03–0.32) μg/l for troponin I, p = 0.005]. The area under the receiving operating characteristic curve (AUC) for diagnosing RVD was 0.93 for BNP and 0.72 for troponin I. The troponin I level increased further when RVD was severe, compared with moderate, and the AUC was 0.91 for identifying severe RVD. Diagnoses of RVD and severe RVD were ruled out by BNP ≤ 100 pg/ml (30% of patients) and troponin I 0.10 μg/l (58% of patients), respectively. In-hospital death or circulatory failure occurred in nine patients; all had echographic RVD and level of BNP > 100 pg/ml and troponin I > 0.10 μg/l. Conclusion In hemodynamically stable pulmonary embolism, BNP/troponin I measurement is helpful on admission, especially for ruling out RVD, i. e. patients with in-hospital high-risk.


  • Open Access

    Percutaneous intracoronary delivery of SERCA gene increases myocardial function: a tissue Doppler imaging echocardiographic study

    by Damien Logeart, Laurent Vinet, Thierry Ragot, Michèle Heimburger, Liliane Louedec, Jean-Baptiste Michel, Brigitte Escoubet, Jean-Jacques Mercadier

    The aim of this study was to examine the efficiency of adenovirus-mediated overexpression of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA1a) gene in a realistic model based on percutaneous intracoronary delivery and on noninvasive functional monitoring. Catheter-based selective coronary delivery of saline or adenoviruses (Ad.CMV.SERCA1a or Ad.CMV.lacZ, 1010plaque-forming units) was performed in the circumflex artery of rabbits. Effects were assessed and compared by using serial Doppler echocardiography, hemodynamics, and measurements of SERCA protein and Ca2+uptake activity. On day 3, a 21% increase in SERCA proteins and a 37% increase in the maximal rate of Ca2+uptake were observed in the transfected left ventricular (LV) walls of Ad.CMV.SERCA1a rabbits. Baseline hemodynamics and conventional echographic measurements of global LV function were poorly affected. In contrast, tissue Doppler imaging (TDI) was able to assess a strong increase in the baseline function of transfected LV walls, as assessed with maximal wall velocities (+32% and +43%, respectively) and strain rates (+18% and +30%, respectively). TDI parameters were closely related to the maximal rate of Ca2+uptake ( r2= 0.68 for the systolic strain rate). Serial TDI analysis during follow-up showed that the effects lasted for 7 days and were no longer detectable 15 days after adenoviruses injection. In conclusion, LV function can be increased by adenovirus-mediated overexpression of SERCA in a clinically relevant model, and TDI provides an accurate and noninvasive tool for monitoring effects on global as well as regional myocardial function.


  • Open Access

    Remodelage précoce du ventricule gauche après un accident coronarien aigu

    by Jean-Jacques Mercadier, Roger Gaertner, Damien Logeart, Jean-Baptiste Michel

    Ventricular remodelling following acute coronary syndromes is both complex and multiform. It is due to the response of the myocardium to the different agressions associated with these syndromes, in particular the ischemia and necrosis downstream of the occluded artery. We must not however neglect the role of the remodelling of the lesions resulting from spontaneous reperfusion or provoked by the cells and tissues associated with coronary microcirculation embolisms and the no-reflow phenomenon. Acute post-infarct remodelling is dominated by early ventricular dilatation which largely affects late prognosis, necrosis elimination and its replacement by a fibrotic scar in parallel with a compensatory hypertrophy of the non-infarcted myocardium. The diverse cellular and molecular components of this remodelling are increasingly well-known, allowing us to better explain the beneficial effects of the currently available medications and providing us with new potential therapeutic targets. A grading of this knowledge associated with the identification of new risk factors and early therapeutic interventions should help us to further limit the deleterious aspects of this remodelling in the goal of preventing, or at least delaying, the devolution towards heart failure.